13-38851093-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_207361.6(FREM2):c.6727C>T(p.Arg2243Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_207361.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FREM2 | NM_207361.6 | c.6727C>T | p.Arg2243Ter | stop_gained | 10/24 | ENST00000280481.9 | NP_997244.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FREM2 | ENST00000280481.9 | c.6727C>T | p.Arg2243Ter | stop_gained | 10/24 | 1 | NM_207361.6 | ENSP00000280481 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250332Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135294
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461440Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727028
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74248
ClinVar
Submissions by phenotype
Finger syndactyly;C0265660:Toe syndactyly;C0266294:Unilateral renal agenesis;C0266362:Ambiguous genitalia;C0311249:Cryptophthalmia;C1857453:Renal hypoplasia/aplasia;C2315717:Cryptotia;C4025329:Abnormality of the anus Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2022 | This sequence change creates a premature translational stop signal (p.Arg2243*) in the FREM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FREM2 are known to be pathogenic (PMID: 18203166, 26552811). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 523570). This variant has not been reported in the literature in individuals affected with FREM2-related conditions. This variant is present in population databases (rs767978562, gnomAD 0.002%). - |
Fraser syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 30, 2022 | Variant summary: FREM2 c.6727C>T (p.Arg2243X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been associated with Cryptophthalmos / Fraser syndrome in HGMD. The variant allele was found at a frequency of 8e-06 in 250332 control chromosomes. To our knowledge, no occurrence of c.6727C>T in individuals affected with Cryptophthalmos Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at